e-learning
resources
Virtual 2020
Pre-Congress Content
Prognostic and predictive factors: treatment of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Survival after intrapleural catheter (IPC) insertion for malignant pleural effusion (MPE): a retrospective audit of prognostic scoring tools in patients with MPE treated with an IPC in a district general hospital.
M. Shuvo (Colchester (Essex), United Kingdom), F. Jarvis (Colchester (Essex), United Kingdom), R. Lee (Colchester (Essex), United Kingdom), L. Wright (Colchester (Essex), United Kingdom), R. Badiger (Colchester (Essex), United Kingdom), P. Hawkins (Colchester (Essex), United Kingdom)
Source:
Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Session:
Prognostic and predictive factors: treatment of lung cancer
Session type:
E-poster session
Number:
1750
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Shuvo (Colchester (Essex), United Kingdom), F. Jarvis (Colchester (Essex), United Kingdom), R. Lee (Colchester (Essex), United Kingdom), L. Wright (Colchester (Essex), United Kingdom), R. Badiger (Colchester (Essex), United Kingdom), P. Hawkins (Colchester (Essex), United Kingdom). Survival after intrapleural catheter (IPC) insertion for malignant pleural effusion (MPE): a retrospective audit of prognostic scoring tools in patients with MPE treated with an IPC in a district general hospital.. 1750
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
A randomised controlled study comparing the outcomes of pleural nurse practitioner (NP) versus doctors trained to perform pleural procedures for management of pleural effusions
Source: Annual Congress 2013 –Interventional pulmonology and pleural diseases
Year: 2013
A 10-year experience of pleurodesis for malignant pleural effusion in a district general hospital
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010
Retrospective analysis of survival time in malignant pleural effusion requiring IPC insertion
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Determinants of survival in patients with malignant pleural mesothelioma (MPM) managed at a single institution in Liguria, Italy
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018
Pleurodesis after intrapleural catheter insertion is an independent factor for overall survival in patients with malignant pleural effusions
Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours
Year: 2009
Are patients with malignant pleural effusions being referred appropriately for surgical intervention?
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
Management of pneumothorax: are we giving the right information to patients upon discharge – an observational study
Source: Annual Congress 2007 - Pleural diseases
Year: 2007
The survival prediction of malignant pleural effusion and the validation of LENT prognosis score in Thai patients.
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017
The second therapeutic intervention in malignant effusion trial (TIME2): A randomised controlled trial to assess the efficacy and safety of patient controlled malignant pleural effusion drainage by indwelling pleural catheter compared to chest drain and talc slurry pleurodesis
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012
Outcome of early medical thoracoscopy in pleural infection.
Source: International Congress 2018 – Pleural interventions
Year: 2018
A review of outcomes of indwelling pleural catheters (IPC) for malignant pleural effusions (MPE) at the Cambridge Pleural unit UK
Source: Annual Congress 2013 –Interventional pulmonology and pleural diseases
Year: 2013
LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
Heterogeneous delivery of definitive interventions in malignant pleural effusions – results from a Danish survey.
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019
Specialist clinic for exudative pleural effusions (EPE) improves outcome
Source: Annual Congress 2008 - Pleural diseases and interventions
Year: 2008
The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020
Thoracoscopy to management of parapneumonic effusion (PPE) in pediatric patients
Source: Eur Respir J 2002; 20: Suppl. 38, 538s
Year: 2002
Survival of patients with malignant pleural effusions: a three-year prospective self-experience study
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018
An audit of intercostal chest drains for pleural effusions in a district general hospital in the UK
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Pleural effusions in medical ICU –prevalence, causes and clinical significance
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009
Thoracoscopic talc pleurodesis‘(TTP) safety and clinical efficacy in malignant pleural effusions (MPE)
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept